NEW YORK, Jan. 5, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Citius Oncology, Inc. (NASDAQ: CTOR) on behalf of the company's shareholders.  The investigation seeks to determine whether Citius Oncology's directors breached their fiduciary duties in connection with recent corporate actions. If you are a shareholder of Citius Oncology and are interested in obtaining additional information about your rights and options, please visit us at: https://pjlfirm.com/citius-oncolog ...